Clarity and Execution in Life Science Operations
Operational due diligence, external manufacturing, supply chain optimisation and transformation, led by senior executives who have owned these challenges at scale.
35+ years of operational leadership
FDA • EMA • MHRA • TGA inspection experience
Multiple due diligence transactions supported over the past 10 years
Multiple CDMO sites assessed from late-stage development to Commercial Manufacturing
In life science operations, performance, compliance and supply reliability are closely connected. Whether assessing an investment, selecting a CDMO, strengthening supply resilience or improving site performance, leaders need clear, practical insight grounded in real operating experience.
Clariveer brings senior-led judgment, direct engagement and execution focus to help clients make better decisions and deliver measurable operational progress.
Operational and regulatory assessments for investors and boards.
CDMO selection, governance design, and performance recovery.
End-to-end diagnostics, planning transformation, and resilience.
Site performance, culture, and execution in regulated environments.
Private equity, venture capital, and strategic investors evaluating targets or managing portfolio performance across Biopharma, MedTech, Nutritionals, and specialty manufacturing.
Growth-stage and mid-sized biotech, pharma, and MedTech companies strengthening external manufacturing, supply chain, and site performance.
35+ years of direct operational leadership at Horizon Therapeutics, Ipsen, and Bristol Myers Squibb. Advice grounded in lived accountability, not theory.
Outputs fit for investment committees and boards - clear, commercial, defensible.
Issues identified early, priorities clear, recommendations ready to implement.
Proven leaders with direct accountability across manufacturing, quality, regulatory, and supply chain.
